Baker Bros. Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-653,562
| Closed | -$10.8M | – | 106 |
|
|
2022
Q4 | $10.8M | Sell |
653,562
-1,116,119
| -63% | -$18.4M | 0.06% | 56 |
|
|
2022
Q3 | $22.6M | Sell |
1,769,681
-305,722
| -15% | -$3.9M | 0.15% | 43 |
|
|
2022
Q2 | $24.3M | Buy |
2,075,403
+1,003,365
| +94% | +$11.7M | 0.14% | 41 |
|
|
2022
Q1 | $6.53M | Hold |
1,072,038
| – | – | 0.04% | 80 |
|
|
2021
Q4 | $9.82M | Hold |
1,072,038
| – | – | 0.05% | 77 |
|
|
2021
Q3 | $12.1M | Hold |
1,072,038
| – | – | 0.05% | 73 |
|
|
2021
Q2 | $10.6M | Sell |
1,072,038
-1,686,480
| -61% | -$16.6M | 0.05% | 76 |
|
|
2021
Q1 | $39M | Buy |
2,758,518
+874,067
| +46% | +$12.4M | 0.17% | 48 |
|
|
2020
Q4 | $21.3M | Sell |
1,884,451
-322,504
| -15% | -$3.64M | 0.08% | 56 |
|
|
2020
Q3 | $29.1M | Buy |
2,206,955
+99,355
| +5% | +$1.31M | 0.12% | 43 |
|
|
2020
Q2 | $22.6M | Buy |
+2,107,600
| New | +$22.6M | 0.1% | 45 |
|